Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans.

Taylor SB, Lewis CR, Olive MF.

Subst Abuse Rehabil. 2013 Feb 8;4:29-43. doi: 10.2147/SAR.S39684. eCollection 2013. Review.

PMID:
24648786
[PubMed]
Free PMC Article
2.

Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Sahin G, Thompson LH, Lavisse S, Ozgur M, Rbah-Vidal L, Dollé F, Hantraye P, Kirik D.

PLoS One. 2014 Mar 10;9(3):e90759. doi: 10.1371/journal.pone.0090759. eCollection 2014.

PMID:
24614598
[PubMed - in process]
Free PMC Article
3.

Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load.

Smith CT, Swift-Scanlan T, Boettiger CA.

J Cogn Neurosci. 2014 Feb;26(2):395-407. doi: 10.1162/jocn_a_00501. Epub 2013 Oct 21.

PMID:
24144248
[PubMed - in process]
Free PMC Article
4.

De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.

Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN; NIH ARRA Autism Sequencing Consortium, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A.

Mol Psychiatry. 2013 Dec;18(12):1315-23. doi: 10.1038/mp.2013.102. Epub 2013 Aug 27.

PMID:
23979605
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia.

Kesby JP, Cui X, Burne TH, Eyles DW.

Front Cell Neurosci. 2013 Jul 17;7:111. doi: 10.3389/fncel.2013.00111. eCollection 2013.

PMID:
23882183
[PubMed]
Free PMC Article
6.

Amphetamine mechanisms and actions at the dopamine terminal revisited.

Calipari ES, Ferris MJ.

J Neurosci. 2013 May 22;33(21):8923-5. doi: 10.1523/JNEUROSCI.1033-13.2013. No abstract available.

PMID:
23699503
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.

Covey DP, Juliano SA, Garris PA.

PLoS One. 2013 May 3;8(5):e60763. doi: 10.1371/journal.pone.0060763. Print 2013.

PMID:
23671560
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices.

Ferris MJ, Calipari ES, Yorgason JT, Jones SR.

ACS Chem Neurosci. 2013 May 15;4(5):693-703. doi: 10.1021/cn400026v. Epub 2013 May 6. Review.

PMID:
23581570
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice.

Afanador L, Mexhitaj I, Diaz C, Ordonez D, Baker L, Angulo JA.

Brain Res. 2013 May 13;1510:38-47. doi: 10.1016/j.brainres.2013.03.010. Epub 2013 Mar 19.

PMID:
23524190
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry.

Omiatek DM, Bressler AJ, Cans AS, Andrews AM, Heien ML, Ewing AG.

Sci Rep. 2013;3:1447. doi: 10.1038/srep01447.

PMID:
23486177
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Chinese Medicine Formula "Jian-Pi-Zhi-Dong Decoction" Attenuates Tourette Syndrome via Downregulating the Expression of Dopamine Transporter in Mice.

Wang DH, Li W, Liu XF, Zhang JM, Wang SM.

Evid Based Complement Alternat Med. 2013;2013:385685. doi: 10.1155/2013/385685. Epub 2013 Feb 3.

PMID:
23431337
[PubMed]
Free PMC Article
12.

Illicit stimulant use is associated with abnormal substantia nigra morphology in humans.

Todd G, Noyes C, Flavel SC, Della Vedova CB, Spyropoulos P, Chatterton B, Berg D, White JM.

PLoS One. 2013;8(2):e56438. doi: 10.1371/journal.pone.0056438. Epub 2013 Feb 13.

PMID:
23418568
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms.

Avelar AJ, Juliano SA, Garris PA.

J Neurochem. 2013 May;125(3):373-85. doi: 10.1111/jnc.12197. Epub 2013 Mar 6.

PMID:
23406303
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.

McDougall SA, Nuqui CM, Quiroz AT, Martinez CM.

Pharmacol Biochem Behav. 2013 Mar;104:154-62. doi: 10.1016/j.pbb.2013.01.016. Epub 2013 Jan 27.

PMID:
23360956
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.

Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, Ragozzino ME, Garris PA, Roitman MF.

J Neurosci. 2013 Jan 9;33(2):452-63. doi: 10.1523/JNEUROSCI.2136-12.2013.

PMID:
23303926
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.

Rodriguez PC, Pereira DB, Borgkvist A, Wong MY, Barnard C, Sonders MS, Zhang H, Sames D, Sulzer D.

Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):870-5. doi: 10.1073/pnas.1213569110. Epub 2012 Dec 31.

PMID:
23277566
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Presynaptic dopamine modulation by stimulant self-administration.

Espana RA, Jones SR.

Front Biosci (Schol Ed). 2013 Jan 1;5:261-76. Review.

PMID:
23277050
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Yarosh HL, Angulo JA.

Brain Res. 2012 Nov 5;1483:31-8. doi: 10.1016/j.brainres.2012.09.013. Epub 2012 Sep 13.

PMID:
22982589
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour.

Latapy C, Rioux V, Guitton MJ, Beaulieu JM.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2460-74. doi: 10.1098/rstb.2012.0094.

PMID:
22826345
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.

Hodgkins P, Shaw M, Coghill D, Hechtman L.

Eur Child Adolesc Psychiatry. 2012 Sep;21(9):477-92. doi: 10.1007/s00787-012-0286-5. Epub 2012 Jul 5. Review.

PMID:
22763750
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk